Skip to main content
. 2023 Feb 7;13:1044327. doi: 10.3389/fonc.2023.1044327

Table 5.

Meta-analysis of the rate of SAEs, pneumonitis, and drug-related death in combination therapy.

Studies Items for evaluation Rate (%) 95%CI
Pembro + Chemo in RCT studies Grade 3-5 TRAEs 64 49-78%
Grade 3-5 IRAEs 10 6-14%
Pneumonitis (≥Grade 3) 4 2-6%
Drug-related death 2 1-4%
Pembro in RCT studies Grade 3-5 TRAEs 20 15-26%
Grade 3-5 IRAEs 9 6-12%
Pneumonitis (≥Grade 3) 3 2-4%
Drug-related death 2 0-3%
Pembro + Chemo in Retrospective studies Grade 3-5 TRAEs 51 40-61%
Pneumonitis (≥Grade 3) 2 -2-6%
Drug-related death 2 -2-6%
Pembro in Retrospective studies Grade 3-5 IRAEs 17 14-21%
Pneumonitis (≥Grade 3) 3 1-5%
Drug-related death 4 -2-10%